Tractivus, a client of ABG’s, has recently been awarded the Seal of Excellence for SMEs within the Horizon 2020 framework for research and innovation by the European Commission. This Award is granted to those companies that demonstrate high quality projects and great potential to open new markets.
The Seal of Excellence is a sign of quality bestowed upon project proposals submitted to Horizon 2020, the EU’s research and innovation funding programme. The aim of this action is to help to find alternative funding.
Tractivus is a company dedicated to developing medical devices resistant to bacterial colonisation, with the help of PHOBOSTech™: This is a very versatile flexible bacteriophobic surface comprising a micro-nanostructured metal coating where bacteria cannot adhere, and which does not use antibiotics. The technology is very promising as a definitive solution for nosocomial infections (infections acquired during a stay in a health centre).
From ABG IP, we are proud of working together with Tractivus since 2016. We wish them the best of the success.